Mitochondrial enzyme FAHD1 reduces ROS in osteosarcoma
A model of how FAHD1 activity may modulate U2OS metabolism. (A) In U2OS cells, the tricarboxylic acid cycle operates independently, relying on both glycolysis and glutaminolysis to sustain the tricarboxylic acid flux. The PEP-PYR-OAA node remains stable, ensuring a consistent supply of mtGDP for the synthesis of succinate (SUC). (B) Overexpression of hFAHD1.1 in U2OS cells enhances glycolysis, leading to a reduction in oxaloacetate levels. This reduction impairs the citrate synthase (CS) reaction, consequently diminishing tricarboxylic acid flux and lowering complex I activity and ROS levels. To compensate for oxaloacetate depletion, the PEP-PYR-OAA node is upregulated, generating mtGDP and SUC. With decreased tricarboxylic acid cycle flux, NAD+ cannot be produced via complex I, prompting cytosolic lactate production to regenerate NAD+. This is facilitated by increased glycolysis. (C) Surprisingly, overexpression of hFAHD1.1-T192S in U2OS cells does not enhance glycolysis but shifts metabolism towards glutaminolysis. Similarly to hFAHD1.1 overexpression, oxaloacetate levels are reduced, impairing CS reaction and lowering tricarboxylic acid flux and complex I activity. As oxaloacetate levels may be drastically reduced, the PEP-PYR-OAA node may not sufficiently compensate. Consequently, the tricarboxylic acid cycle may be maintained through glutaminolysis. NADP+ may be generated via reductive isocitrate dehydrogenase 2 (IDH2) activity, or NAD+ via the nicotinamide (NAM) salvage pathway. Oxaloacetate may also be replenished through a non-canonical tricarboxylic acid cycle, involving citrate export into the cytosol (via SLC25A1), reduction, and subsequent import of malate and NAD+ into mitochondria. Malate can then be converted to oxaloacetate, providing fuel for complex I. (D) Overexpression of hFAHD1.1-K123A in U2OS cells appears to bypass glycolysis, downregulating PC, FAHD1, and PEPCK-M. This likely indicates a catalytic knockdown of FAHD1 via overexpression of a loss-of-function variant. Although the underlying mechanisms require further elucidation, it seems that glycolysis and the PEP-PYR-OAA node may be completely shut down, with cells relying solely on glutaminolysis. Despite similarities to the wild-type setup (A), this metabolic rerouting is weaker. Consequently, these cells exhibit increased mitochondrial content to compensate but otherwise behave similarly to wild-type cells in most experiments, including nearly unchanged ROS levels. Regulation of fumarate (FUM) levels may occur through adjacent pathways to compensate for the lack of biosynthesis.
Publication
Mitochondrial enzyme FAHD1 reduces ROS in osteosarcoma. (2024) Anne Heberle, et al. Sci Rep. 2024;14:9231. Figure: F8.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | PEP | PEP | ncbigene_synonym | PAEP | 5047 |
| Homo sapiens | Primates | PEP | PEP | ncbigene_synonym | PREP | 5550 |
| Homo sapiens | Primates | PEP | PEP | ncbigene_synonym | PTPN22 | 26191 |
| Homo sapiens | Primates | ADP | ADP | ncbigene_synonym | WDTC1 | 23038 |
| Homo sapiens | Primates | ATP | ATP | ncbigene_synonym | ATP8A2 | 51761 |
| Homo sapiens | Primates | LON | LON | ncbigene_synonym | LONP1 | 9361 |
| Homo sapiens | Primates | SLC25A51 | SLC25A51 | ncbigene_symbol | SLC25A51 | 92014 |
| Homo sapiens | Primates | HAD | HAD | ncbigene_synonym | HADH | 3033 |
| Homo sapiens | Primates | [POH] | POH | ncbigene_synonym | GNAS | 2778 |
| Homo sapiens | Primates | MAL | MAL | ncbigene_symbol | MAL | 4118 |
| Homo sapiens | Primates | MAL | MAL | ncbigene_synonym | MRTFA | 57591 |
| Homo sapiens | Primates | MAL | MAL | ncbigene_synonym | TIRAP | 114609 |
| Homo sapiens | Primates | SLC25A1 | SLC25A1 | ncbigene_symbol | SLC25A1 | 6576 |
| Homo sapiens | Primates | [PC] | PC | ncbigene_symbol | PC | 5091 |
| Homo sapiens | Primates | CIT | CIT | ncbigene_symbol | CIT | 11113 |
| Homo sapiens | Primates | CIT | CIT | ncbigene_synonym | DHDDS | 79947 |
| Homo sapiens | Primates | NADPH | NADPH | ncbigene_synonym | DECR1 | 1666 |
| Homo sapiens | Primates | Clas | CLA | ncbigene_synonym | SELPLG | 6404 |
| Homo sapiens | Primates | Clas | CIA | ncbigene_synonym | ASF1A | 25842 |
| Homo sapiens | Primates | Clas | CIA | ncbigene_synonym | NCOA5 | 57727 |
| Homo sapiens | Primates | dal | DAI | ncbigene_synonym | ZBP1 | 81030 |
| Homo sapiens | Primates | GLS | GLS | ncbigene_symbol | GLS | 2744 |
| Homo sapiens | Primates | GLS | GLS | ncbigene_synonym | GLS2 | 27165 |
| Homo sapiens | Primates | HADH | HADH | ncbigene_synonym | HADHA | 3030 |
| Homo sapiens | Primates | ACLY | ACLY | ncbigene_symbol | ACLY | 47 |
| Homo sapiens | Primates | Ac | ADCY | famplex_relations | ADCY1 | 107 |
| Homo sapiens | Primates | Ac | ADCY | famplex_relations | ADCY2 | 108 |
| Homo sapiens | Primates | Ac | ADCY | famplex_relations | ADCY3 | 109 |
| Homo sapiens | Primates | Ac | ADCY | famplex_relations | ADCY4 | 196883 |
| Homo sapiens | Primates | Ac | ADCY | famplex_relations | ADCY5 | 111 |
| Homo sapiens | Primates | Ac | ADCY | famplex_relations | ADCY6 | 112 |
| Homo sapiens | Primates | Ac | ADCY | famplex_relations | ADCY7 | 113 |
| Homo sapiens | Primates | Ac | ADCY | famplex_relations | ADCY8 | 114 |
| Homo sapiens | Primates | Ac | ADCY | famplex_relations | ADCY9 | 115 |
| Homo sapiens | Primates | Ac | ADCY | famplex_relations | ADCY10 | 55811 |
| Homo sapiens | Primates | MAD | MAD | ncbigene_synonym | AMPD1 | 270 |
| Homo sapiens | Primates | MAD | MAD | ncbigene_synonym | MXD1 | 4084 |
| Homo sapiens | Primates | RAD | RAD | ncbigene_synonym | RRAD | 6236 |
| Homo sapiens | Primates | НАДЕРЖ | HP | ncbigene_symbol | HP | 3240 |
| Homo sapiens | Primates | НАДЕРЖ | HEP | ncbigene_synonym | EPHB6 | 2051 |
| Homo sapiens | Primates | НАДЕРЖ | HEP | ncbigene_synonym | DNLZ | 728489 |
| Homo sapiens | Primates | GS] | GS | famplex_relations | GNAL | 2774 |
| Homo sapiens | Primates | (LDH) | LDH | famplex_relations | LDHA | 3939 |
| Homo sapiens | Primates | (LDH) | LDH | famplex_relations | LDHB | 3945 |
| Homo sapiens | Primates | (LDH) | LDH | famplex_relations | LDHC | 3948 |
| Homo sapiens | Primates | GEN | GEN | ncbigene_synonym | GEN1 | 348654 |
| Homo sapiens | Primates | TTP | TTP | ncbigene_synonym | ZFP36 | 7538 |
| Homo sapiens | Primates | TTP | TTP | ncbigene_synonym | SH3BP4 | 23677 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| PEP | PEP | 2-(phosphonooxy)prop-2-enoic acid | chebi:44897 | |
| ADP | ADP | L-alanyl-L-alpha-aspartyl-L-proline | chebi:73342 | |
| ATP | ATP | ATP | chebi:30616 | |
| Glucose | Glucose | aldehydo-D-glucose | chebi:42758 | |
| ATP | ATP | ATP | chebi:30616 | |
| NAD | NAD | adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate} | chebi:15846 | |
| Lactate | lactate | lactate | chebi:24996 | |
| Glucose | Glucose | aldehydo-D-glucose | chebi:42758 | |
| NAD | NAD | adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate} | chebi:15846 | |
| PEP | PEP | 2-(phosphonooxy)prop-2-enoic acid | chebi:44897 | |
| Lactate | lactate | lactate | chebi:24996 | |
| PEP | PEP | 2-(phosphonooxy)prop-2-enoic acid | chebi:44897 | |
| NAD | NAD | adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate} | chebi:15846 | |
| PEP | PEP | 2-(phosphonooxy)prop-2-enoic acid | chebi:44897 | |
| NAD | NAD | adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate} | chebi:15846 | |
| ATP | ATP | ATP | chebi:30616 | |
| ATP | ATP | ATP | chebi:30616 | |
| NADH | NADH | adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate} | chebi:57945 | |
| NAD | NAD | adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate} | chebi:15846 | |
| MAL | mal | malate | chebi:15595 | |
| CIT | Cit | N(5)-carbamoyl-L-ornithine | chebi:16349 | |
| MAL | mal | malate | chebi:15595 | |
| NADPH | NADPH | 2'-O-phosphonatoadenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate} | chebi:57783 | |
| NAD | NAD | adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate} | chebi:15846 | |
| NADH | NADH | adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate} | chebi:57945 | |
| NADH | NADH | adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate} | chebi:57945 | |
| NAD | NAD | adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate} | chebi:15846 | |
| CIT | Cit | N(5)-carbamoyl-L-ornithine | chebi:16349 | |
| MAL | mal | malate | chebi:15595 | |
| NADH | NADH | adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate} | chebi:57945 | |
| Clas | CLAs | chebi:61159 | ||
| dal | DAL | D-alanine | chebi:15570 | |
| NAD | NAD | adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate} | chebi:15846 | |
| GLU | Glu | 2-aminopentanedioic acid | chebi:18237 | |
| GLN | Gln | L-glutamine residue | chebi:30011 | |
| NAD | NAD | adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate} | chebi:15846 | |
| NADH | NADH | adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate} | chebi:57945 | |
| NADH | NADH | adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate} | chebi:57945 | |
| NADH | NADH | adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate} | chebi:57945 | |
| OAA | OAA | chebi:132560 | ||
| CIT | Cit | N(5)-carbamoyl-L-ornithine | chebi:16349 | |
| NADH | NADH | adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate} | chebi:57945 | |
| ATP | ATP | ATP | chebi:30616 | |
| PEP | PEP | 2-(phosphonooxy)prop-2-enoic acid | chebi:44897 | |
| NADH | NADH | adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate} | chebi:57945 | |
| NAD | NAD | adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate} | chebi:15846 | |
| OAA | OAA | chebi:132560 | ||
| CIT | Cit | N(5)-carbamoyl-L-ornithine | chebi:16349 | |
| MAL | mal | malate | chebi:15595 | |
| NAD | NAD | adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate} | chebi:15846 | |
| MAD | MAD | L-methionyl-L-alanyl-L-aspartic acid | chebi:73609 | |
| GLU | Glu | 2-aminopentanedioic acid | chebi:18237 | |
| NAD | NAD | adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate} | chebi:15846 | |
| NAD | NAD | adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate} | chebi:15846 | |
| NADH | NADH | adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate} | chebi:57945 | |
| ATP | ATP | ATP | chebi:30616 | |
| ADP | ADP | L-alanyl-L-alpha-aspartyl-L-proline | chebi:73342 | |
| NADH | NADH | adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate} | chebi:57945 | |
| ATP | ATP | ATP | chebi:30616 | |
| NADA | NADA | N-[2-(3,4-dihydroxyphenyl)ethyl]acetamide | chebi:125678 | |
| NAD | NAD | adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate} | chebi:15846 | |
| GLN | Gln | L-glutamine residue | chebi:30011 | |
| MAL | mal | malate | chebi:15595 | |
| DGL | DGL | (2R)-2-aminopentanedioic acid | chebi:15966 | |
| NAD | NAD | adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate} | chebi:15846 | |
| GLU | Glu | 2-aminopentanedioic acid | chebi:18237 | |
| GLN | Gln | L-glutamine residue | chebi:30011 | |
| NADH | NADH | adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate} | chebi:57945 | |
| NADH | NADH | adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate} | chebi:57945 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|